128 related articles for article (PubMed ID: 38618884)
1. Genetic variants of unknown significance in alpha-galactosidase A: Cellular delineation from Fabry disease.
Klein A; Klug K; Breyer M; Grüner J; Medala VK; Nordbeck P; Wanner C; Klopocki E; Üçeyler N
J Inherit Metab Dis; 2024 Apr; ():. PubMed ID: 38618884
[TBL] [Abstract][Full Text] [Related]
2.
Breyer M; Grüner J; Klein A; Finke L; Klug K; Sauer M; Üçeyler N
Mol Genet Metab Rep; 2024 Mar; 38():101029. PubMed ID: 38469097
[TBL] [Abstract][Full Text] [Related]
3. Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant.
Lenders M; Weidemann F; Kurschat C; Canaan-Kühl S; Duning T; Stypmann J; Schmitz B; Reiermann S; Krämer J; Blaschke D; Wanner C; Brand SM; Brand E
Orphanet J Rare Dis; 2016 May; 11(1):54. PubMed ID: 27142856
[TBL] [Abstract][Full Text] [Related]
4. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
Rosa Neto NS; Bento JCB; Pereira RMR
Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease due to D313Y and novel GLA mutations.
Koulousios K; Stylianou K; Pateinakis P; Zamanakou M; Loules G; Manou E; Kyriklidou P; Katsinas C; Ouzouni A; Kyriazis J; Speletas M; Germenis AE
BMJ Open; 2017 Oct; 7(10):e017098. PubMed ID: 28988177
[TBL] [Abstract][Full Text] [Related]
7. Cardiomyopathy associated with the Ala143Thr variant of the
Valtola K; Nino-Quintero J; Hedman M; Lottonen-Raikaslehto L; Laitinen T; Maria M; Kantola I; Naukkarinen A; Laakso M; Kuusisto J
Heart; 2020 Apr; 106(8):609-615. PubMed ID: 31949022
[TBL] [Abstract][Full Text] [Related]
8. Nationwide screening for Fabry disease in unselected stroke patients.
Tomek A; Petra R; Paulasová Schwabová J; Olšerová A; Škorňa M; Nevšímalová M; Šimůnek L; Herzig R; Fafejtová Š; Mikulenka P; Táboříková A; Neumann J; Brzezny R; Sobolová H; Bartoník J; Václavík D; Vachová M; Bechyně K; Havlíková H; Prax T; Šaňák D; Černíková I; Ondečková I; Procházka P; Rajner J; Škoda M; Novák J; Škoda O; Bar M; Mikulík R; Dostálová G; Linhart A;
PLoS One; 2021; 16(12):e0260601. PubMed ID: 34905550
[TBL] [Abstract][Full Text] [Related]
9. The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease.
Hasholt L; Ballegaard M; Bundgaard H; Christiansen M; Law I; Lund AM; Norremolle A; Krogh Rasmussen A; Ravn K; Tumer Z; Wibrand F; Feldt-Rasmussen U
Scand J Clin Lab Invest; 2017 Dec; 77(8):617-621. PubMed ID: 29037082
[TBL] [Abstract][Full Text] [Related]
10. Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease.
Niemann M; Rolfs A; Giese A; Mascher H; Breunig F; Ertl G; Wanner C; Weidemann F
JIMD Rep; 2013; 7():99-102. PubMed ID: 23430502
[TBL] [Abstract][Full Text] [Related]
11. Is the alpha-galactosidase A variant p.Asp313Tyr (p.D313Y) pathogenic for Fabry disease? A systematic review.
Effraimidis G; Rasmussen ÅK; Bundgaard H; Sørensen SS; Feldt-Rasmussen U
J Inherit Metab Dis; 2020 Sep; 43(5):922-933. PubMed ID: 32246457
[TBL] [Abstract][Full Text] [Related]
12. The mutation p.D313Y is associated with organ manifestation in Fabry disease.
du Moulin M; Koehn AF; Golsari A; Dulz S; Atiskova Y; Patten M; Münch J; Avanesov M; Ullrich K; Muschol N
Clin Genet; 2017 Nov; 92(5):528-533. PubMed ID: 28276057
[TBL] [Abstract][Full Text] [Related]
13.
Palaiodimou L; Stefanou MI; Bakola E; Papadopoulou M; Kokotis P; Vrettou AR; Kapsia E; Petras D; Anastasakis A; Xifaras N; Karachaliou E; Touloumi G; Vlachopoulos C; Boletis IN; Giannopoulos S; Tsivgoulis G; Zompola C
Neurology; 2022 Nov; 99(19):e2188-e2200. PubMed ID: 36344272
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for Fabry disease in the north-west of Spain.
Colon C; Ortolano S; Melcon-Crespo C; Alvarez JV; Lopez-Suarez OE; Couce ML; Fernández-Lorenzo JR
Eur J Pediatr; 2017 Aug; 176(8):1075-1081. PubMed ID: 28646478
[TBL] [Abstract][Full Text] [Related]
15. D313Y variant in two related end-stage renal disease patients - Pathogenic or not yet?
Vicente R; Santos I; Coimbra M; Santos J; Santos R; Amoedo M; Pires C
Nefrologia (Engl Ed); 2023; 43(5):636-639. PubMed ID: 36517364
[TBL] [Abstract][Full Text] [Related]
16. Elevated Lyso-Gb3 Suggests the R118C GLA Mutation Is a Pathological Fabry Variant.
Talbot A; Nicholls K
JIMD Rep; 2019; 45():95-98. PubMed ID: 30569317
[TBL] [Abstract][Full Text] [Related]
17. Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y.
Oder D; Üçeyler N; Liu D; Hu K; Petritsch B; Sommer C; Ertl G; Wanner C; Nordbeck P
BMJ Open; 2016 Apr; 6(4):e010422. PubMed ID: 27059467
[TBL] [Abstract][Full Text] [Related]
18. Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry disease.
Namdar M; Gebhard C; Studiger R; Shi Y; Mocharla P; Schmied C; Brugada P; Lüscher TF; Camici GG
PLoS One; 2012; 7(4):e36373. PubMed ID: 22558451
[TBL] [Abstract][Full Text] [Related]
19. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.
De Brabander I; Yperzeele L; Ceuterick-De Groote C; Brouns R; Baker R; Belachew S; Delbecq J; De Keulenaer G; Dethy S; Eyskens F; Fumal A; Hemelsoet D; Hughes D; Jeangette S; Nuytten D; Redondo P; Sadzot B; Sindic C; Sheorajpanday R; Thijs V; Van Broeckhoven C; De Deyn PP
Clin Neurol Neurosurg; 2013 Jul; 115(7):1088-93. PubMed ID: 23219219
[TBL] [Abstract][Full Text] [Related]
20. Impact of
Monda E; Diana G; Graziani F; Rubino M; Bakalakos A; Linhart A; Germain DP; Scarpa M; Biagini E; Pieroni M; Elliott PM; Limongelli G
Circ Genom Precis Med; 2023 Dec; 16(6):e004252. PubMed ID: 38047356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
